background Several studies have shown that obese persons have lower circulating natriuretic peptide (NP) concentrations. The cause of the relative NP deficiency seen in obese persons is poorly understood, although variation in body composition and metabolic abnormalities has been suggested to play a role. Thus, the aim of this study was to assess whether variation in circulating NP concentrations would be associated with differences in metabolic disturbances rather than with differences in body composition.
Since its discovery in the mid-1980s, evidence has accumulated to suggest that the cardiac natriuretic peptides (NPs) play an important role in salt and water homeostasis and blood pressure (BP) control. [1] [2] [3] [4] Several studies have shown that obese persons have lower circulating NP concentrations than normal weight persons, [5] [6] [7] [8] [9] [10] and it has been suggested that the relative NP deficiency or "natriuretic handicap" seen in obese persons could be 1 mechanism by which obesity promotes hypertension. The cause of the relative NP deficiency seen in obese persons is still not clear, although variation in body composition and obesity-related metabolic disturbances has been suggested to play a role. [6] [7] [8] [9] [11] [12] [13] [14] Thus, the objective of this study was to assesses whether variation in circulating NP concentrations would be associated with differences in metabolic disturbances rather than with differences in body composition in a population consisting of 27 normal weight and 103 obese generally healthy men.
METHODS

Study population
Participants were recruited by advertising and from 2 population-based studies from the Research Centre for Prevention and Health, Copenhagen University Hospital Glostrup, Denmark. The study program was primarily initiated to shed new light on the pathophysiology of obesityrelated hypertension. 15 We aimed to study at least 100 obese men (body mass index (BMI) ≥ 30 kg/m 2 ), with or without hypertension, and at least 25 normal weight men (BMI ≤ 25 kg/m 2 ) who were normotensive. To achieve this goal, we screened and examined 115 obese men and 33 normal weight men. Inclusion criteria for the obese men were BMI ≥ 30 kg/m 2 , aged 25-69 years, never treated for hypertension, no medication in the 3 weeks before the study, no diagnosis of diabetes and a screening fasting plasma glucose <7.0 mmol/L, no cardiovascular disease or other chronic diseases, no nighttime work, and a complete set of data. The criteria for the normal weight men were the same except for BMI of 20.0-24.9 kg/m 2 and mean 24-hour ambulatory blood pressure (ABP) <130/80 mm Hg. In total 103 obese men and 27 normal weight normotensive men fulfilled all criteria and were included. All men were white.
The study was conducted according to the principles of the Helsinki Declaration, and all participants gave informed written consent before inclusion. The study was approved by the Danish Ethical Committee (HB-2007-040).
Body composition
Body weight with subjects in underwear was measured to the nearest 0.1 kg, and height was measured to the nearest 0.1 cm. Waist and hip circumference was measured as illustrated in Figure 1 . We used dual energy x-ray absorptiometry (DXA) scanning (GE Lunar, Madison, WI) to determine body composition accurately. Total body scans were auto-analyzed with software version 11.0. The android and gynoid regions were defined according to the default software readings, as shown in Figure 1 . The various body composition measurements are expressed as percentage muscle mass, percentage total fat mass, and so on. One investigator performed all the analyses.
Blood samples
Fasting blood samples were obtained from a brachial vein. After separation (serum or EDTA plasma), the samples were stored at −80 °C until analyses. 
Cardiac NP system
The activity of the cardiac NP system was assessed by measuring circulating concentrations of midregional proatrial NP (MR-proANP) and brain NP (BNP). We chose to measure MR-proANP concentrations rather than Atrial natriuretic peptide (ANP) because ANP is a very labile molecule with short plasma half-life. 16 MR-proANP in serum was measured with a commercially available sandwich chemiluminescence immunoassay (BRAHMS AG, Hennigsdorf/Berlin, Germany). The assay has a limit of quantitation of 6.0 pmol/L. The intra-assay coefficients of variation are <10% and <20% for samples containing 23-3,000 pmol/L and 18-22.9 pmol/L MR-proANP, respectively. Interassay coefficients of variation are 20% for a MR-proANP concentration of 18 pmol/L and 10% for a proANP concentration of 65 pmol/L. Serum concentrations of BNP were measured with a commercially available chemiluminescent microparticle immunoassay on an Architect System (Abbott Laboratories, Chicago, IL). The sensitivity of the assay is ≤10 pg/ml, and the intraassay and interassay coefficients of variation are <5% and <5%, respectively
Metabolic measurements
Plasma glucose concentrations were measured by an automated analyzer (Roche Diagnostics, Mannheim, Germany). Serum insulin concentrations were measured with a commercial enzyme-linked immunosorbent assay kit (DAKoCytomation, Cambridgeshire, UK). The degree of insulin resistance was assessed by the homeostasis model of assessment of insulin resistance (HOMA-IR). 17 Total blood cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides were measured using standard laboratory techniques.
BP measurements
BP was measured by automatic 24-hour ABP recordings (Spacelabs ABP 90207; Spacelabs, Redmont, CA). Daytime was set from 7:00 am to 11:00 pm, and BP was measured every 20 minutes. Nighttime was set from 11:00 pm to 7:00 am, unless the subject reported other sleeping habits, and BP was measured every 30 minutes during nighttime. A cuff size of 14 cm was chosen for 24-32-cm upper arm circumference, and a cuff size of 16 cm was chosen for >32-cm upper arm circumference. To fulfill the criteria for a complete dataset, the 24-hour ABP recording required at least 14 readings during daytime and at least 7 readings during nighttime in accordance with the European guidelines for ABP measurements. 18 
Lifestyle information
Information about smoking habits, alcohol consumption, physical activity, and parental history of hypertension and diabetes and other medical conditions was obtained from a questionnaire. Participants, who were sedentary or only active <4 hours per week, were defined as having a low level of physical activity. All participants were interviewed about sleep disorders. 19 
Definition of hypertension
Presence of hypertension and normotension was defined according to the recommendations from the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes as a mean 24-hour systolic BP ≥130 mm Hg and/or a mean 24-hour diastolic BP ≥80 mmHg and a mean 24-hour BP <130/80 mm Hg, respectively. 20 
Statistical analysis
Data analyses were performed using SPSS version 17.0 (SPSS, Chicago, IL). Unless stated otherwise, continuous data are presented as mean ± SD or median (interquartile range) for data with normal and skewed distributions, respectively. Group comparisons of continuous data were performed using analysis of variance. Non-normally distributed data were log-transformed to fulfill the normal distribution criteria. χ 2 was used for group comparisons for categorical data. Multiple regression analyses were applied to explore independent relationships between selected variables of interest. The results of the analyses are presented as standardized regression coefficients (ß). In the various multiple regression models, MR-proANP, BNP, and insulin were log-transformed to fulfill model assumptions. Furthermore, in the multiple regressions, the study population was entered as a weight status variable (normal weight vs. obese), and to ensure that the various identified associations were the same in the 2 groups, we tested for significant interaction effects between metabolic measurements or body composition measurements and weight status on serum NP concentrations. All statistical tests were 2-sided. P < 0.05 was considered significant.
RESULTS
A total of 27 normal weight men and 103 obese men were included in the study (Table 1) . Of the obese men, 63 were diagnosed with hypertension for the first time. The 2 groups did not differ significantly with respect to age, smoking, or physical activity (P > 0.10), but more of the obese men had a parental history of hypertension (P = 0.003). Anthropometric and hemodynamic parameters were as expected in the 2 groups. Accordingly, the obese men had higher weight, BMI, and body fat measurements than the normal weight men (P < 0.001), and they had higher 24-hour ABP values than the normal weight men (P < 0.001). Mean 24-hour heart rate was also higher in the obese men (P = 0.04). None of the participants qualified for a diagnosis of sleep apnea. Of note, although there was a rather narrow range of BMI values (30.4-39.1 kg/m 2 ) among the 103 obese men, the range of body composition values varied more than 2-fold (total fat mass: 18.9%-44.9%; android fat mass: 23.2%-57.8%; gynoid fat mass: 23.1%-50.9%).
The obese men had higher fasting concentrations of triglycerides and lower fasting concentrations of high-density lipoprotein cholesterol than the normal weight men (P < 0.006) ( Table 1) . Furthermore, the obese men had higher fasting concentrations of glucose and insulin than the normal weight men (P < 0.001), and they had lower circulating concentrations of BNP (P = 0.04) and MR-proANP (P = 0.002) than the normal weight men.
Overall circulating BNP concentrations showed only weak associations (ß = −0.21 to 0.23) ( Table 2) . Nevertheless, BNP concentrations were negatively associated with fasting plasma glucose concentrations (P = 0.004), fasting serum insulin concentrations (P = 0.02), and HOMA-IR (P = 0.04) and positively associated with total body weight (P = 0.04), but no significant association was found between BNP and any of the body composition measurements (P > 0.06). In contrast, serum MR-proANP concentrations showed robust inverse associations with fasting serum insulin concentrations (r = −0.39; P < 0.0001) and HOMA-IR (r = −0.38; P < 0.001) ( Table 2) but not with any of the measurements of anthropometry or body composition (P > 0.25). Furthermore, no significant interaction effects between metabolic measurements or body composition measurements and weight status on MR-proANP and BNP concentrations were found (P > 0.08). Finally, the fact that abnormalities in insulin and glucose metabolism were associated with lower circulating NP concentrations, are also seen in Figure 2 , which shows box plots of serum MR-proANP and BNP concentrations stratified by HOMI-IR < and ≥2.0 units.
We also thought it interesting to examine the relationships between serum insulin concentrations or HOMA-IR units and circulating NP concentrations, adjusting for age, weight status, total fat mass percentage, and systolic BP or diastolic BP or pulse pressure using multiple regression analysis. Higher serum insulin concentrations were still related to lower circulating MR-proANP concentrations (standardized regression coefficients of −0.40 to −0.36; P < 0.0001) after controlling for BP (Table 3) . Similar results were found for HOMA-IR (data not shown). Furthermore, higher insulin concentrations were also significantly, albeit weakly, related to lower serum BNP concentrations (standardized regression coefficients of −0.21 to −0.18; P < 0.02) in the models described above.
DISCUSSION
The principal finding of this study was that in generally healthy normal weight and obese men lower circulating NP concentrations were associated with higher serum insulin concentrations and higher plasma glucose concentrations and not with the proportion of total fat mass or the distribution of fat mass, with the strongest relationships found between MR-proANP and insulin concentrations and HOMA-IR. Furthermore, we found that, despite much higher 24-hour systolic ABP levels (a mean difference of 18 ± 13 mm Hg; P < 0.001) and much higher 24-hour diastolic ABP levels (a mean difference of 8 ± 7 mm Hg; P < 0.001) than the normal weight men, the obese men still had significantly lower serum concentrations of both MR-proANP and BNP, clearly demonstrating that the obese men had a substantial natriuretic handicap. We speculate that this relative NP deficiency may contribute significantly to their higher BP levels.
To the best of our knowledge, only 1 other study has so far explored the impact of body mass and body composition on circulating concentrations of NPs using DXA scanning: the Dallas Heart Study (DHS). 7 The DHS, a large, populationbased study in Texas analyzed data from 2,707 subjects aged 30-65 years. 7 The DHS measured plasma concentrations of both BNP and N-terminal proBNP (NT-proBNP) and reported the DXA scanning measurements in absolute values (kg) not relative values (%). In contrast with our study, the DHS included women, black persons, patients with ischemic heart disease, and hypertensive patients taking BP-lowering drugs. 21 The DHS found an inverse association between circulating NP concentrations and BMI, and the DHS investigators also found, much to their surprise, that the inverse association between BMI and BNP and NT-proBNP was mediated by higher lean mass rather than higher fat mass. In this context, we found a weak positive relationship between BNP and muscle mass in absolute values (kg) (r = 0.17; P = 0.02). So far, the DHS has not presented data on insulin, BNP, and NT-proBNP.
A number of studies have explored the relationship between subcutaneous and visceral (intra-abdominal) fat area (mass) and circulating NP concentrations using computed tomography. 11, 12 Two studies included measurements of fasting serum insulin and fasting plasma glucose concentrations, 11, 12 and both studies found significant inverse associations between insulin and NP concentrations, as we did. In a substudy from the Framingham Heart Study, which included 1,873 women and men, circulating NT-proBNP concentrations were found to be inversely related to visceral adipose tissue mass, 11 and for comparison, circulating NT-proBNP concentrations were found to be more strongly related to visceral fat mass than to subcutaneous fat mass. 11 Furthermore, the Framingham Heart Study investigators reported that the association between plasma NT-proBNP concentrations and visceral adipose tissue mass was substantially attenuated by adjustment for HOMA-IR. 11 Accordingly they suggested that hyperinsulinemia could be a mediator of the link between visceral adipose tissue mass and lower circulating NP concentrations. 11 In the Victor J study, which included 500 male Japanese workers, ageadjusted regression analysis showed that plasma BNP concentrations correlated negatively with visceral fat area and fasting serum insulin concentrations, but not with BMI or subcutaneous fat area. 12 Furthermore in this study, stepwise multiple regression analysis identified fasting serum insulin concentrations, but not visceral fat area, as a significant and independent determinant of circulating BNP concentrations, 12 which together with various stratified analyses led the Victor J study investigators to conclude that hyperinsulinemia correlates with low concentrations of plasma BNP irrespective of fat distribution. 12 The underlying mechanisms for the lower circulating NP concentrations found in obese and hyperinsulinemic persons are poorly understood, although NP secretion, elimination, and degradation have been studied extensively. 1, 22, 23 In this context, it is worthy of note that the obesity-related natriuretic handicap does not seem to by related to less myocardial wall stress (distension), which is generally considered the main mechanical stimulus for NP production and secretion by the cardiac myocytes. 1 Thus, in otherwise generally well-matched patients undergoing cardiac catheterization, circulating BNP and NT-proBNP concentrations were lower in obese patients despite significantly higher left ventricular end-diastolic pressure (and similar left ventricular ejection fraction). 24 This finding clearly suggests that factors other than cardiac status impact on BNP and NT-proBNP concentrations in obese persons. Substantial evidence has been accumulated to suggest that impaired cardiac NP secretion may play a role in the natriuretic handicap observed in obese and hyperinsulinemic persons. Thus, 1 study showed that ANP concentrations failed to rise appropriately in obese persons after an acute intravenous saline load. 25 Furthermore, in patients undergoing cardiac catheterization, it was recently shown that plasma BNP concentrations at the coronary sinus minus plasma BNP concentrations at the aortic root, which is regarded as an index of cardiac BNP secretion, was negatively correlated with BMI and serum insulin concentrations and HOMA-IR. 13 This led the authors to conclude that the lower circulating BNP concentrations observed in obese and hyperinsulinemic persons are primarily the result of decreased cardiac BNP secretion. 13 In this context it is worthy of note that experimental animal studies have found that obesity and hyperinsulinemia are associated with ectopic lipid deposition, also in the heart, which may directly exert a lipotoxic effect on the myocardium, leading to impaired production and secretion of the cardiac NPs. 23, 26 Evidence has also been presented to suggest that an increased clearance of active NPs by means of an increased expression of NP clearance receptors on adipocytes may contribute to the lower circulating concentrations of NPs seen in obese and hyperinsulinemic persons. 23, [27] [28] [29] However, it is also recognized that such increases do not explain the lower circulating concentrations of NT-proANP and other natriuretic prohormones in obese and hyperinsulinemic persons because these receptors do not bind natriuretic prohormones. 23 This lack of binding of inactive NPs therefore also points indirectly to impaired cardiac NP secretion as a possible important factor in the natriuretic handicap found in obese and hyperinsulinemic persons. Nevertheless, in 30 patients with atrial fibrillation undergoing pulmonary vein isolation, which made it possible to estimate systemic and pulmonary ANP clearance rate, systemic ANP clearance rate was found to be positively correlated with BMI. 29 Thus, an increased systemic NP clearance may also contribute to the lower circulating concentrations of NPs seen in obese and hyperinsulinemic persons.
The cross-sectional nature of this study is a limitation and does not allow us to draw conclusions with respect to causeand-effect relationships. It is also a limitation that the DXA scanning technique, which we used, only measures total body fat mass or total regional fat mass and does not allow accurate assessment of visceral fat mass. Such an assessment could have been done by the computed tomography scanning or magnetic resonance imaging technique. It is a great strength of this study that we only included generally healthy men without cardiovascular disease and not taking any medicine. This made it possible for us to study "clean" metabolic relationships, which increases the credibility of our results. Finally, we cannot rule out that if we had used another study population, including participants with BMI values ranging, e.g., 18-50 kg/m 2 , then we would also have been able to find significant negative associations between body composition measurements and circulating NP concentrations, such as was reported in 2 large, populationbased studies that included participants with a wide range of BMI values by Khan and colleagues. 9 This study adds to the growing body of evidence to suggest that important connections exist between the endocrine heart and metabolic pathways, and these connections may very well be bidirectional. Thus, it is well-established that the NPs can stimulate lipolysis in human adipocytes. 23, 30, 31 Furthermore, it was recently shown that the cardiac NPs can induce the brown fat thermogenic program in mouse and human adipocytes 32 and also enhance the oxidative capacity of human skeletal muscle. 33 How this possible crosstalk between the endocrine heart and metabolic pathways, including insulin resistance with compensatory hyperinsulinemia, and between the endocrine heart and muscle and adipose tissue eventually may help to increase our knowledge on the pathogenesis of obesity-related hypertension awaits further studies. Nevertheless, this link between metabolism and the cardiac NP system, which plays an important role in salt and water homeostasis and BP control, 1-4 may be a reasonable cause of at least some fraction of obesity-related hypertension.
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